Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: improving global outcomes (KDIGO)
PMID: 122 PhilippouEPeterssonSDRodomarCNikiphorouE
Drug working concentrations and stock preparation were as follows: GLP-1MK-801 and MK-801 (both 50 M, dissolved in aCSF or magnesium-free aCSF), NMDA (100 M, dissolved in magnesium free aCSF), CNQX (10 M, dissolved in DMSO, Alomone Labs), picrotoxin (100 M, dissolved in DMSO)
ACA Marketplace Plans : Health insurance plans sold through federal or state exchanges, often with income-based premium subsidies
It does not lead to withdrawal symptoms or memory impairment, distinguishing it from traditional anxiolytic medications